pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles
- PMID: 20100555
- DOI: 10.1016/j.ijpharm.2010.01.030
pDNA condensation capacity and in vitro gene delivery properties of cationic solid lipid nanoparticles
Abstract
Cationic solid lipid nanoparticles (SLN) are promising nonviral gene delivery carriers suitable for systemic administration. The objective of this study was to investigate the relationship between the composition of cationic SLN and their ability to condense plasmid DNA (pDNA) and to transfer it in neuroblastoma cells. The SLN were prepared by using stearic acid and stearylamine as lipid core along with Esterquart 1 (EQ1) or Protamine obtaining two samples (SLN-EQ1 and SLN-Protamine, respectively). The cationic SLN were freeze-dried after preparation and their physical-chemical properties, including the surface composition and the transfection efficiency were investigated. The results showed that the two samples had similar size, zeta potential and pDNA binding properties but SLN-Protamine were able to condense pDNA more efficaciously than SLN-EQ1 forming smaller and less positive complexes. SLN-Protamine:pDNA complexes demonstrated to be less cytotoxic and more efficient in the transfection of Na1300 cell line than SLN-EQ1:pDNA. These findings were attributed to the different surface composition of the two samples and in particular to the localization of the Protamine on the surface of the particle while EQ1 in the lipid core. In conclusion the results here suggest that not only the z-potential but also the surface composition may affect the pDNA condensation proprieties and thus the transfection efficiency of nonviral gene nanocarriers.
Copyright 2010 Elsevier B.V. All rights reserved.
Similar articles
-
Nuclear localization of cationic solid lipid nanoparticles containing Protamine as transfection promoter.Eur J Pharm Biopharm. 2010 Nov;76(3):384-93. doi: 10.1016/j.ejpb.2010.07.012. Epub 2010 Aug 4. Eur J Pharm Biopharm. 2010. PMID: 20691262
-
Design flexibility influencing the in vitro behavior of cationic SLN as a nonviral gene vector.Int J Pharm. 2013 Jan 20;440(2):161-9. doi: 10.1016/j.ijpharm.2012.08.055. Epub 2012 Sep 11. Int J Pharm. 2013. PMID: 22982257
-
The role of protamine amount in the transfection performance of cationic SLN designed as a gene nanocarrier.Drug Deliv. 2012 Jan;19(1):1-10. doi: 10.3109/10717544.2011.621989. Epub 2011 Nov 9. Drug Deliv. 2012. PMID: 22070724
-
Chemical vectors for gene delivery: uptake and intracellular trafficking.Curr Opin Biotechnol. 2010 Oct;21(5):640-5. doi: 10.1016/j.copbio.2010.07.003. Epub 2010 Jul 30. Curr Opin Biotechnol. 2010. PMID: 20674331 Review.
-
How cationic lipids transfer nucleic acids into cells and across cellular membranes: recent advances.J Control Release. 2013 Feb 28;166(1):46-56. doi: 10.1016/j.jconrel.2012.12.014. Epub 2012 Dec 20. J Control Release. 2013. PMID: 23266451 Review.
Cited by
-
Comparative Analysis of the Physicochemical and Biological Characteristics of Freeze-Dried PEGylated Cationic Solid Lipid Nanoparticles.Pharmaceuticals (Basel). 2023 Nov 9;16(11):1583. doi: 10.3390/ph16111583. Pharmaceuticals (Basel). 2023. PMID: 38004448 Free PMC article.
-
Overcoming Gene-Delivery Hurdles: Physiological Considerations for Nonviral Vectors.Trends Biotechnol. 2016 Feb;34(2):91-105. doi: 10.1016/j.tibtech.2015.11.004. Epub 2015 Dec 23. Trends Biotechnol. 2016. PMID: 26727153 Free PMC article. Review.
-
The Astonishing Accomplishment of Biological Drug Delivery using Lipid Nanoparticles: An Ubiquitous Review.Curr Pharm Biotechnol. 2024;25(15):1952-1968. doi: 10.2174/0113892010268824231122041237. Curr Pharm Biotechnol. 2024. PMID: 38265380 Review.
-
Exploring the potential of nanomedicine for gene therapy across the physicochemical and cellular barriers.Funct Integr Genomics. 2024 Sep 28;24(5):177. doi: 10.1007/s10142-024-01459-z. Funct Integr Genomics. 2024. PMID: 39340586 Review.
-
Novel Nanocomplexes Targeting STAT3 Demonstrate Promising Anti-Ovarian Cancer Effects in vivo.Onco Targets Ther. 2020 Jun 8;13:5069-5082. doi: 10.2147/OTT.S247398. eCollection 2020. Onco Targets Ther. 2020. PMID: 32606729 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical